Dana Horáková

Charles University — Czech Republic

Medicine · Health Sciences

49h-index8.7kcitations380works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(260), Peripheral Neuropathies and Disorders(52), Rheumatoid Arthritis Research and Therapies(38), Polyomavirus and related diseases(36), Systemic Sclerosis and Related Diseases(34)

Publications377 total

Managing reactivation of multiple sclerosis during treatment with natalizumab
Multiple Sclerosis Journal·2025Open Access
Big multiple sclerosis data network: novel modelling approaches for real-world data analysis
Journal of Neurology·2025
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry·2025
Disease course after pregnancy in women with progressive multiple sclerosis symptoms
Multiple Sclerosis Journal·2025Open Access
Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million Inhabitants
International Journal of Molecular Sciences·2025Open Access
Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Coun-tries Covering 107 Million Inhabitants
Preprints.org·2025Open Access
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
Multiple Sclerosis Journal·2025Open Access
<scp>SARS</scp>‐<scp>CoV</scp>‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis
Annals of Clinical and Translational Neurology·2025· 1 citedOpen Access
RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis
Frontiers in Neurology·2025· 1 citedOpen Access
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Multiple Sclerosis Journal·2025· 2 citedOpen Access
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
JAMA Neurology·2025· 20 citedOpen Access
T1 and T2 Mapping Improves Correlation of Disability and Brain Atrophy Beyond Lesional Measures in Patients with Multiple Sclerosis (P3-1.015)
Neurology·2025
Trajectories of Serum NfL and GFAP Levels in Newly Diagnosed Multiple Sclerosis Patients After Initiation of Immunomodulatory Treatments (P6-1.012)
Neurology·2025
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Journal of Neurology Neurosurgery & Psychiatry·2024· 1 citedOpen Access
RIMLA: Reproducibility-Informed Method for Longitudinal Assessment
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Cross-sectional multiparametric subtyping of multiple sclerosis lesions informs on their longitudinal evolution
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD
Neurology·2024· 16 cited
Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study
Acta Neurologica Belgica·2024· 3 citedOpen Access
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Neurology Neuroimmunology & Neuroinflammation·2024· 16 citedOpen Access
Lipid measures are associated with cognitive functioning in multiple sclerosis patients
Multiple Sclerosis and Related Disorders·2024· 2 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Eva Havrdová(40), Manuela Vaněčková(23), Tomáš Kalinčík(22), Helmut Butzkueven(19), Pierre Grammond(18), María Trojano(17), Vincent Van Pesch(17), Robert Zivadinov(17), Zdeněk Seidl(17), Jan Krásenský(17), Guillermo Izquierdo(16), Marc Girard(16), Pierre Duquette(16), Alessandra Lugaresi(15), François Grand’Maison(15), Cavit Boz(15), Jeannette Lechner‐Scott(15), Tim Spelman(14), Raymond Hupperts(14), Patrizia Sola(14)